The gut microbiota plays a critical role in the pathogenesis and progression of NAFLD by regulation of gut permeability, changes in luminal metabolism of bile acid and food substrates, and production of lipoprotein lipase, endogenous alcohol, and toxic compounds [4–9]. The gene discussed is LPL; the disease is metabolic dysfunction-associated steatotic liver disease.